Late-Breaking Abstracts

LBP5 Real-life data of anifrolumab as a treatment for systemic lupus erythematosus (SLE)

Pub Date : 2024-03-01 DOI: 10.1136/lupus-2024-el.226 Laura Salvador Maicas, J. Fragio, P. M. Calabuig, R. G. Mazarío, Mireia Luciía Sanmartín Martínez, C. M. Almela, A. Cid, Juan Joseí Lerma Garrido, Cristina Campos Fernaíndez

LBP2 Development and validation of a patient-centered autoevaluation questionnaire in systemic lupus erythematosus: LUPIN

Pub Date : 2024-03-01 DOI: 10.1136/lupus-2024-el.223 M. Scherlinger, J. Kleinmann, Antonin Folliasson, Marianne Riviere, Raphaëlle Rybak, Sabine Malivoir, J. Viallard, Frédéric Renou, Estibaliz Lazaro, C. Richez, Pascal Roblot, Mathieu Puyade, Clara Baverez, Arnaud Hot, Christophe Deligny, Nicolas Baillet, Daniel Wendling, Julien Campagne, Christian Agard, R. Jaussaud, T. Moulinet, Denis Wahl, G. Blaison, Elisabeth Diot, N. Ferreira-Maldent, Isabelle Marie, Nicolas Girszyn, L. Perard, Marc André, P. Orquevaux, A. Servettaz, F. Chasset, Baptiste Hervier, Thierry Martin, Cécile Fermont, Emmanuelle David, Loic Raffray, L. Trefond, Perrine Smets, Julie Lescanff, J. Gottenberg, Xavier Mariette, Zahir Amoura, Jean Sibilia

LBO2 Long-term renal and cardiovascular risks of tacrolimus in lupus nephritis patients

Pub Date : 2024-03-01 DOI: 10.1136/lupus-2024-el.221 Mieke van Schaik, O. W. Bredewold, Merel Priester, Wieneke M Michels, Ton J Rabelink, J. Rotmans, YK Onno Teng